| Prevalence of problematic smartphone usage and associated mental health outcomes amongst children and young people: a systematic review, meta-analysis and GRADE of the evidence SY Sohn, P Rees, B Wildridge, NJ Kalk, B Carter BMC psychiatry 19, 1-10, 2019 | 638 | 2019 |
| Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [11C]PBR28 PET Brain Imaging Study PS Bloomfield, S Selvaraj, M Veronese, G Rizzo, A Bertoldo, DR Owen, ... American Journal of Psychiatry 173 (1), 44-52, 2016 | 468 | 2016 |
| Investigation into the neural correlates of emotional augmentation of clinical pain P Schweinhardt, N Kalk, K Wartolowska, I Chessell, P Wordsworth, ... Neuroimage 40 (2), 759-766, 2008 | 193 | 2008 |
| Neuroinflammation in treated HIV-positive individuals: a TSPO PET study JH Vera, Q Guo, JH Cole, A Boasso, L Greathead, P Kelleher, EA Rabiner, ... Neurology 86 (15), 1425-1432, 2016 | 164 | 2016 |
| Determination of [11C]PBR28 Binding Potential in vivo: A First Human TSPO Blocking Study DR Owen, Q Guo, NJ Kalk, A Colasanti, D Kalogiannopoulou, R Dimber, ... Journal of Cerebral Blood Flow & Metabolism 34 (6), 989-994, 2014 | 141 | 2014 |
| The clinical pharmacology of acamprosate NJ Kalk, AR Lingford‐Hughes British journal of clinical pharmacology 77 (2), 315-323, 2014 | 128 | 2014 |
| The association between smartphone addiction and sleep: a UK cross-sectional study of young adults SY Sohn, L Krasnoff, P Rees, NJ Kalk, B Carter Frontiers in psychiatry 12, 629407, 2021 | 114 | 2021 |
| Alcohol and Alzheimer's disease—does alcohol dependence contribute to beta-amyloid deposition, neuroinflammation and neurodegeneration in Alzheimer's disease? A Venkataraman, N Kalk, G Sewell, CW Ritchie, A Lingford-Hughes Alcohol and Alcoholism 52 (2), 151-158, 2017 | 114 | 2017 |
| The role of central noradrenergic dysregulation in anxiety disorders: evidence from clinical studies NJ Kalk, DJ Nutt, AR Lingford-Hughes Journal of Psychopharmacology 25 (1), 3-16, 2011 | 90 | 2011 |
| 11C-PBR28 and 18F-PBR111 detect white matter inflammatory heterogeneity in multiple sclerosis G Datta, A Colasanti, N Kalk, D Owen, G Scott, EA Rabiner, RN Gunn, ... Journal of Nuclear Medicine 58 (9), 1477-1482, 2017 | 68 | 2017 |
| Decreased hippocampal translocator protein (18 kDa) expression in alcohol dependence: a [11C] PBR28 PET study NJ Kalk, Q Guo, D Owen, R Cherian, D Erritzoe, A Gilmour, AS Ribeiro, ... Translational psychiatry 7 (1), e996-e996, 2017 | 64 | 2017 |
| Neuropharmacology of addiction and how it informs treatment A Lingford-Hughes, B Watson, N Kalk, A Reid British medical bulletin 96 (1), 93-110, 2010 | 55 | 2010 |
| Acute increases in synaptic GABA detectable in the living human brain: a [11C] Ro15-4513 PET study PRA Stokes, JF Myers, NJ Kalk, BJ Watson, D Erritzoe, SJ Wilson, ... Neuroimage 99, 158-165, 2014 | 49 | 2014 |
| The Imperial College Cambridge Manchester (ICCAM) platform study: an experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: study … LM Paterson, RSA Flechais, A Murphy, LJ Reed, S Abbott, V Boyapati, ... Journal of Psychopharmacology 29 (9), 943-960, 2015 | 45 | 2015 |
| Patient information on schizophrenia on the internet † NJ Kalk, DD Pothier Psychiatric Bulletin 32 (11), 409-411, 2008 | 42 | 2008 |
| Characterisation of the Contribution of the GABA-Benzodiazepine α1 Receptor Subtype to [11C]Ro15-4513 PET Images JFM Myers, L Rosso, BJ Watson, SJ Wilson, NJ Kalk, N Clementi, ... Journal of Cerebral Blood Flow & Metabolism 32 (4), 731-744, 2012 | 40 | 2012 |
| Measurement of GABA using J‐difference edited 1H‐MRS following modulation of synaptic GABA concentration with tiagabine JFM Myers, CJ Evans, NJ Kalk, RAE Edden, AR Lingford‐Hughes Synapse 68 (8), 355-362, 2014 | 38 | 2014 |
| Pharmacological treatment of mood disorders and comorbid addictions: a systematic review and meta-analysis: traitement pharmacologique des Troubles de L’humeur et des … PRA Stokes, T Jokinen, S Amawi, M Qureshi, MI Husain, LN Yatham, ... The Canadian Journal of Psychiatry 65 (11), 749-769, 2020 | 36 | 2020 |
| A pilot study of the effectiveness of d-cycloserine during cue-exposure therapy in abstinent alcohol-dependent subjects BJ Watson, S Wilson, L Griffin, NJ Kalk, LG Taylor, MR Munafò, ... Psychopharmacology 216, 121-129, 2011 | 36 | 2011 |
| Spicing it up-synthetic cannabinoid receptor agonists and psychosis-a systematic review M Hobbs, NJ Kalk, PD Morrison, JM Stone European Neuropsychopharmacology 28 (12), 1289-1304, 2018 | 35 | 2018 |
